Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1956 3
1957 2
1958 2
1959 3
1961 4
1962 7
1963 11
1964 26
1965 17
1966 13
1967 15
1968 20
1969 30
1970 30
1971 16
1972 20
1973 22
1974 29
1975 25
1976 21
1977 29
1978 37
1979 39
1980 42
1981 35
1982 60
1983 55
1984 72
1985 91
1986 123
1987 117
1988 120
1989 150
1990 119
1991 118
1992 163
1993 142
1994 159
1995 169
1996 170
1997 179
1998 159
1999 191
2000 196
2001 179
2002 197
2003 191
2004 207
2005 217
2006 245
2007 219
2008 232
2009 302
2010 308
2011 341
2012 366
2013 364
2014 357
2015 406
2016 343
2017 369
2018 395
2019 407
2020 484
2021 490
2022 420
2023 335
2024 269

Text availability

Article attribute

Article type

Publication date

Search Results

9,730 results

Results by year

Filters applied: . Clear all
Page 1
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.
Sakamoto T, Matsubara T, Takahama T, Yokoyama T, Nakamura A, Tokito T, Okamoto T, Akamatsu H, Oki M, Sato Y, Tobino K, Ikeda S, Mori M, Mimura C, Maeno K, Miura S, Harada T, Nishimura K, Hiraoka M, Kenmotsu H, Fujimoto J, Shimokawa M, Yamamoto N, Nakagawa K. Sakamoto T, et al. Among authors: mori m. JAMA Netw Open. 2023 Dec 1;6(12):e2347700. doi: 10.1001/jamanetworkopen.2023.47700. JAMA Netw Open. 2023. PMID: 38100106 Free PMC article.
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.
Tahara M, Oeda T, Okada K, Kiriyama T, Ochi K, Maruyama H, Fukaura H, Nomura K, Shimizu Y, Mori M, Nakashima I, Misu T, Umemura A, Yamamoto K, Sawada H. Tahara M, et al. Among authors: mori m. Lancet Neurol. 2020 Apr;19(4):298-306. doi: 10.1016/S1474-4422(20)30066-1. Epub 2020 Mar 18. Lancet Neurol. 2020. PMID: 32199095 Clinical Trial.
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
Bahaj W, Kewan T, Gurnari C, Durmaz A, Ponvilawan B, Pandit I, Kubota Y, Ogbue OD, Zawit M, Madanat Y, Bat T, Balasubramanian SK, Awada H, Ahmed R, Mori M, Meggendorfer M, Haferlach T, Visconte V, Maciejewski JP. Bahaj W, et al. Among authors: mori m. J Hematol Oncol. 2023 Aug 3;16(1):91. doi: 10.1186/s13045-023-01480-y. J Hematol Oncol. 2023. PMID: 37537667 Free PMC article.
IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma.
Kofuji S, Hirayama A, Eberhardt AO, Kawaguchi R, Sugiura Y, Sampetrean O, Ikeda Y, Warren M, Sakamoto N, Kitahara S, Yoshino H, Yamashita D, Sumita K, Wolfe K, Lange L, Ikeda S, Shimada H, Minami N, Malhotra A, Morioka S, Ban Y, Asano M, Flanary VL, Ramkissoon A, Chow LML, Kiyokawa J, Mashimo T, Lucey G, Mareninov S, Ozawa T, Onishi N, Okumura K, Terakawa J, Daikoku T, Wise-Draper T, Majd N, Kofuji K, Sasaki M, Mori M, Kanemura Y, Smith EP, Anastasiou D, Wakimoto H, Holland EC, Yong WH, Horbinski C, Nakano I, DeBerardinis RJ, Bachoo RM, Mischel PS, Yasui W, Suematsu M, Saya H, Soga T, Grummt I, Bierhoff H, Sasaki AT. Kofuji S, et al. Among authors: mori m. Nat Cell Biol. 2019 Aug;21(8):1003-1014. doi: 10.1038/s41556-019-0363-9. Epub 2019 Aug 1. Nat Cell Biol. 2019. PMID: 31371825 Free PMC article.
Reprogramming of gastrointestinal cancer cells.
Dewi D, Ishii H, Haraguchi N, Nishikawa S, Kano Y, Fukusumi T, Ohta K, Miyazaki S, Ozaki M, Sakai D, Satoh T, Nagano H, Doki Y, Mori M. Dewi D, et al. Among authors: mori m. Cancer Sci. 2012 Mar;103(3):393-9. doi: 10.1111/j.1349-7006.2011.02184.x. Epub 2012 Jan 17. Cancer Sci. 2012. PMID: 22151786 Free PMC article. Review.
Cancer stem cells in relation to treatment.
Miyoshi N, Mizushima T, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. Jpn J Clin Oncol. 2019 Mar 1;49(3):232-237. doi: 10.1093/jjco/hyy186. Jpn J Clin Oncol. 2019. PMID: 30541049 Review.
COVID-19: clinical issues from the Japan Surgical Society.
Mori M, Ikeda N, Taketomi A, Asahi Y, Takesue Y, Orimo T, Ono M, Kuwayama T, Nakamura S, Yamada Y, Kuroda T, Yuzawa K, Hibi T, Nagano H, Unno M, Kitagawa Y. Mori M, et al. Surg Today. 2020 Aug;50(8):794-808. doi: 10.1007/s00595-020-02047-x. Epub 2020 Jul 11. Surg Today. 2020. PMID: 32651686 Free PMC article. Review.
Isolated ocular flutter.
Nasu S, Uzawa A, Mori M, Kuwabara S. Nasu S, et al. Among authors: mori m. Neurology. 2013 Feb 26;80(9):867. doi: 10.1212/WNL.0b013e31828407a8. Neurology. 2013. PMID: 23439702 No abstract available.
9,730 results